JSRグループのKBIと Selexis がジュネーブのバイオ医薬品製造施設拡張工事完了を報告
JSR株式会社のライフサイエンス事業のグループ企業であるKBI Biopharma, Inc（以下、KBI）とSelexis SA（以下、Selexis）は、スイスのジュネーブで進めていたバイオ医薬品製造設備の拡張を完了し、オペレーションを開始したことを発表しました。本施設の拡張は2020年10月22日に発表したものです。
Read articleNews topics
JSR Life Sciences
JSR Life Sciences is committed to the advancement of human health worldwide as a strategic partner to companies that discover, develop & deliver products to treat disease & improve quality of life
Crown Bioscience
Crown Bioscience is a global CRO providing preclinical and translational platforms to advance oncology, immuno-oncology, and immune-mediated inflammatory diseases
Selexis
Selexis is the global leader in mammalian cell line development that leverages best-in-class protein expression technologies & modular workflows to create highly specialized solutions
KBI Biopharma
KBI Biopharma is an award winning CDMO providing fully-integrated, accelerated drug development & biomanufacturing services to pharmaceutical & biotechnology companies globally
MBL
MBL is committed to being a leading manufacturer & supplier of diagnostic reagents that facilitate further advances in personalized medicine & individualization of medical care
JSR Corporation
JSR Corporation's mission is to contribute to social good by supplying materials to serve future generations & providing new value today for their customers & society